Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rosario Dueñas García"'
Autor:
Victor Navarro Pérez, Natalia Luque Caro, David Fernández Garay, María Ruiz Sanjuan, Miguel Angel Moreno Jimenez, Pedro López Leiva, Ana Laura Ortega Granados, Capilla de la Torre Cabrera, Maria Carmen Álamo de la Gala, Rosario Dueñas García, Esther Martínez Ortega, Francisco José García Verdejo, Yessica Plata Fernández, Juan Francisco Marín Pozo, Nuria Cárdenas Quesada, Rosa Millán García, Mónica Fernández Navarro, Ana Jaén Morago, Maria Lomas Garrido, Pedro Sánchez Rovira
Publikováno v:
Journal of Clinical Oncology. 35:e20515-e20515
e20515 Background: It is known that outcome of patients included in clinical trials have a better outcome than patients treated with standard therapy. This is a retrospective case-control study of outcome of patients with stage III and IV non-small c
Autor:
Ana María Lozano Barriuso, Natalia Luque Caro, Victor Navarro Pérez, Yessica Plata Fernández, Mónica Fernández Navarro, Esther Martínez Ortega, Nuria Cárdenas Quesada, Ana Jaén Morago, María Ruiz Sanjuan, José Pérez del Palacio, Rosario Dueñas García, Capilla de la Torre Cabrera, Francisca Vicente Pérez, Ana Laura Ortega Granados, Pedro Sánchez Rovira, David Fernández Garay, Francisco José García Verdejo, Maria Carmen Álamo de la Gala, Caridad Díaz Navarro, Olga Genilloud
Publikováno v:
Journal of Clinical Oncology. 35:e15504-e15504
e15504 Background: Perioperative chemotherapy (QT) with platinum and fluoropyrimidines with or without anthracyclines is recommended option in patients with resectable gastric cancer (GC) at least cT2 or nodal involvement. Another option is surgery f
Autor:
Ana Laura Ortega Granados, Francisco José García Verdejo, Nuria Cárdenas Quesada, Carmen Garrido, Natalia Luque Caro, Esther Martínez Ortega, Pedro López Leiva, Pedro Sánchez Rovira, María Ruiz Sanjuan, Ana Jaén Morago, Irene Gonzalez Cebrian, Rosario Dueñas García, Yessica Plata Fernández, Monica Fernandez-Navarro, José E. Alés-Martínez, Miguel Angel Moreno Jimenez
Publikováno v:
Journal of Clinical Oncology. 34:e21521-e21521
e21521Background: In our institution, median age of patients with lung cancer is 71. We decide to study how are treated patients over 80 years. Methods: We performed a retrospective observational s...
Autor:
Begoña Medina Magan, Encarna Fernandez Flores, Margarita Fernandez Morales, Pedro Sánchez Rovira, Miguel Angel Moreno Moreno, Ana María Lozano Barriuso, Rosario Dueñas García, Ana Jaén Morago, Ignacio Porras Quintela, N. Mohedano
Publikováno v:
American journal of clinical oncology. 26(4)
A phase II study was conducted to evaluate the safety and efficacy of the combination GIP (gemcitabine, ifosfamide, and cisplatin) for the treatment of patients with advanced non-small-cell lung cancer (NSCLC). Thirty patients with stage III B/IV NSC